H.U. Group Holdings Inc

H.U. Group Holdings, Inc., through its subsidiaries, primarily provides clinical laboratory testing services in Japan. Its clinical laboratory testing services include collecting consigned specimens of patients from hospitals, clinics, and other medical institutions; and conducting analyses and reporting the test results back to these institutions. The company provides testing services in the areas of endocrinology, oncology, plasma protein disorders, virology, immunoserology, immunohematology, blood coagulation system, biochemistry, drug analysis, genetics, human leukocyte antigen, cellular immunity, pathology, cytodiagnosis, and other medical scientific analysis. It also develops, manufactures, and sells in vitro diagnostic reagents and assay instruments for infectious diseases and tumors to medical institutions, commercial laboratories, and blood centers; provides healthcare related services, such as sterilizing and clinical trials support; and rents and sells nursing-care equipment and supplies. In addition, the company offers home-visit nursing and long-term care. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was founded in 1950 and is headquartered in Tokyo, Japan.